US Stock MarketDetailed Quotes

Vor Biopharma (VOR)

Watchlist
  • 13.810
  • -0.810-5.54%
Close Apr 24 15:59 ET
  • 14.200
  • +0.390+2.82%
Post 19:51 ET
748.30MMarket Cap-0.20P/E (TTM)

Vor Biopharma (VOR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-43.20%-142.71M
5.24%-22.8M
-130.46%-53.66M
-61.05%-35.18M
-1.97%-31.07M
0.63%-99.66M
-0.15%-24.06M
16.54%-23.29M
9.35%-21.85M
-25.54%-30.47M
Net income from continuing operations
-495.29%-695.98M
5,709.72%1.72B
-2,848.89%-812.68M
-5,552.75%-1.57B
-5.46%-32.49M
0.81%-116.91M
-16.95%-30.71M
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
Operating gains losses
18,450.00%3.3M
---2.09B
--790.46M
--1.3B
--1K
---18K
----
----
----
----
Depreciation and amortization
-18.17%2.89M
-97.34%23K
-99.76%2K
134.41%2.04M
-12.51%825K
1.03%3.53M
-3.03%865K
-4.70%851K
-0.11%869K
12.66%943K
Other non cash items
10,176.23%518.03M
13,688.05%334.5M
-33,846.21%-44.55M
18,026.46%226.76M
6.33%1.31M
6.64%5.04M
-50.37%2.43M
105.33%132K
6.20%1.25M
8.17%1.23M
Change In working capital
204,060.00%10.21M
12.22%3.16M
5,208.08%5.06M
228.76%4.63M
35.97%-2.64M
-99.23%5K
461.49%2.82M
-107.81%-99K
68.02%1.41M
-508.57%-4.12M
-Change in prepaid assets
301.68%1.68M
-3,737.50%-873K
55.62%-75K
14,215.00%2.86M
67.46%-231K
-125.54%-835K
-96.63%24K
-149.13%-169K
-99.09%20K
-10,242.86%-710K
-Change in payables and accrued expense
387.73%10.93M
68.32%6.21M
931.13%5M
98.91%1.1M
44.68%-1.37M
-21.37%2.24M
2,043.60%3.69M
-81.76%485K
414.95%551K
-2,720.45%-2.48M
-Change in other current assets
--0
-1,738.76%-2.11M
-72.60%151K
10.99%1.95M
300.00%14K
228.72%2.43M
117.77%129K
167.36%551K
468.13%1.76M
-105.22%-7K
-Change in other current liabilities
37.18%-2.41M
94.24%-59K
97.93%-20K
-39.17%-1.28M
-13.79%-1.05M
-6.89%-3.83M
-9.28%-1.02M
-5.34%-966K
8.01%-919K
-26.16%-921K
Cash from discontinued investing activities
Operating cash flow
-43.20%-142.71M
5.24%-22.8M
-130.46%-53.66M
-61.05%-35.18M
-1.97%-31.07M
0.63%-99.66M
-0.15%-24.06M
16.54%-23.29M
9.35%-21.85M
-25.54%-30.47M
Investing cash flow
Cash flow from continuing investing activities
-150.39%-48.8M
-67,919.44%-48.97M
-617.65%-244K
-98.78%646K
-100.52%-230K
36.40%96.86M
-100.70%-72K
-100.08%-34K
288.52%52.99M
576.72%43.97M
Net PPE purchase and sale
37.99%-142K
-336.11%-314K
-617.65%-244K
7,288.89%647K
-102.63%-231K
78.58%-229K
35.14%-72K
92.69%-34K
97.74%-9K
-21.28%-114K
Net investment purchase and sale
-150.12%-48.66M
---48.66M
--0
-100.00%-1K
-100.00%1K
34.70%97.09M
--0
--0
277.54%53M
568.80%44.09M
Cash from discontinued investing activities
Investing cash flow
-150.39%-48.8M
-67,919.44%-48.97M
-617.65%-244K
-98.78%646K
-100.52%-230K
36.40%96.86M
-100.70%-72K
-100.08%-34K
288.52%52.99M
576.72%43.97M
Financing cash flow
Cash flow from continuing financing activities
843.60%503.81M
477.64%307.8M
52,458.54%21.55M
564,825.81%175.07M
-731.25%-606K
1,717.29%53.39M
213,044.00%53.29M
-76.70%41K
-114.22%-31K
-96.19%96K
Net common stock issuance
487.92%328.21M
454.58%307.95M
18,149.55%20.26M
--0
--0
1,119.42%55.83M
370,286.67%55.53M
-71.68%111K
-115.89%-92K
-92.32%278K
Proceeds from stock option exercised by employees
163,920.37%176.93M
-122.89%-19K
2,864.29%1.94M
286,891.80%175.07M
69.78%-55K
88.30%-108K
107.50%83K
67.59%-70K
116.90%61K
52.85%-182K
Net other financing activities
43.01%-1.33M
---131K
---643K
--0
---551K
-224.27%-2.33M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
843.60%503.81M
477.64%307.8M
52,458.54%21.55M
564,825.81%175.07M
-731.25%-606K
1,717.29%53.39M
213,044.00%53.29M
-76.70%41K
-114.22%-31K
-96.19%96K
Net cash flow
Beginning cash position
149.79%84.36M
190.94%160.63M
145.88%192.99M
10.73%52.46M
149.79%84.36M
-43.82%33.77M
16.38%55.21M
126.68%78.49M
5.59%47.38M
-43.82%33.77M
Current changes in cash
517.31%312.29M
709.66%236.02M
-39.00%-32.36M
351.68%140.53M
-334.50%-31.9M
292.02%50.59M
313.31%29.15M
-281.66%-23.28M
403.74%31.11M
189.20%13.6M
End cash Position
370.18%396.65M
370.18%396.65M
190.94%160.63M
145.88%192.99M
10.73%52.46M
149.79%84.36M
149.79%84.36M
16.38%55.21M
126.68%78.49M
5.59%47.38M
Free cash flow
-43.81%-143.65M
4.23%-23.12M
-131.17%-53.91M
-61.68%-35.34M
-2.35%-31.3M
1.45%-99.89M
0.01%-24.14M
17.78%-23.32M
10.79%-21.86M
-25.52%-30.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -43.20%-142.71M5.24%-22.8M-130.46%-53.66M-61.05%-35.18M-1.97%-31.07M0.63%-99.66M-0.15%-24.06M16.54%-23.29M9.35%-21.85M-25.54%-30.47M
Net income from continuing operations -495.29%-695.98M5,709.72%1.72B-2,848.89%-812.68M-5,552.75%-1.57B-5.46%-32.49M0.81%-116.91M-16.95%-30.71M16.97%-27.56M7.14%-27.84M-8.34%-30.8M
Operating gains losses 18,450.00%3.3M---2.09B--790.46M--1.3B--1K---18K----------------
Depreciation and amortization -18.17%2.89M-97.34%23K-99.76%2K134.41%2.04M-12.51%825K1.03%3.53M-3.03%865K-4.70%851K-0.11%869K12.66%943K
Other non cash items 10,176.23%518.03M13,688.05%334.5M-33,846.21%-44.55M18,026.46%226.76M6.33%1.31M6.64%5.04M-50.37%2.43M105.33%132K6.20%1.25M8.17%1.23M
Change In working capital 204,060.00%10.21M12.22%3.16M5,208.08%5.06M228.76%4.63M35.97%-2.64M-99.23%5K461.49%2.82M-107.81%-99K68.02%1.41M-508.57%-4.12M
-Change in prepaid assets 301.68%1.68M-3,737.50%-873K55.62%-75K14,215.00%2.86M67.46%-231K-125.54%-835K-96.63%24K-149.13%-169K-99.09%20K-10,242.86%-710K
-Change in payables and accrued expense 387.73%10.93M68.32%6.21M931.13%5M98.91%1.1M44.68%-1.37M-21.37%2.24M2,043.60%3.69M-81.76%485K414.95%551K-2,720.45%-2.48M
-Change in other current assets --0-1,738.76%-2.11M-72.60%151K10.99%1.95M300.00%14K228.72%2.43M117.77%129K167.36%551K468.13%1.76M-105.22%-7K
-Change in other current liabilities 37.18%-2.41M94.24%-59K97.93%-20K-39.17%-1.28M-13.79%-1.05M-6.89%-3.83M-9.28%-1.02M-5.34%-966K8.01%-919K-26.16%-921K
Cash from discontinued investing activities
Operating cash flow -43.20%-142.71M5.24%-22.8M-130.46%-53.66M-61.05%-35.18M-1.97%-31.07M0.63%-99.66M-0.15%-24.06M16.54%-23.29M9.35%-21.85M-25.54%-30.47M
Investing cash flow
Cash flow from continuing investing activities -150.39%-48.8M-67,919.44%-48.97M-617.65%-244K-98.78%646K-100.52%-230K36.40%96.86M-100.70%-72K-100.08%-34K288.52%52.99M576.72%43.97M
Net PPE purchase and sale 37.99%-142K-336.11%-314K-617.65%-244K7,288.89%647K-102.63%-231K78.58%-229K35.14%-72K92.69%-34K97.74%-9K-21.28%-114K
Net investment purchase and sale -150.12%-48.66M---48.66M--0-100.00%-1K-100.00%1K34.70%97.09M--0--0277.54%53M568.80%44.09M
Cash from discontinued investing activities
Investing cash flow -150.39%-48.8M-67,919.44%-48.97M-617.65%-244K-98.78%646K-100.52%-230K36.40%96.86M-100.70%-72K-100.08%-34K288.52%52.99M576.72%43.97M
Financing cash flow
Cash flow from continuing financing activities 843.60%503.81M477.64%307.8M52,458.54%21.55M564,825.81%175.07M-731.25%-606K1,717.29%53.39M213,044.00%53.29M-76.70%41K-114.22%-31K-96.19%96K
Net common stock issuance 487.92%328.21M454.58%307.95M18,149.55%20.26M--0--01,119.42%55.83M370,286.67%55.53M-71.68%111K-115.89%-92K-92.32%278K
Proceeds from stock option exercised by employees 163,920.37%176.93M-122.89%-19K2,864.29%1.94M286,891.80%175.07M69.78%-55K88.30%-108K107.50%83K67.59%-70K116.90%61K52.85%-182K
Net other financing activities 43.01%-1.33M---131K---643K--0---551K-224.27%-2.33M----------------
Cash from discontinued financing activities
Financing cash flow 843.60%503.81M477.64%307.8M52,458.54%21.55M564,825.81%175.07M-731.25%-606K1,717.29%53.39M213,044.00%53.29M-76.70%41K-114.22%-31K-96.19%96K
Net cash flow
Beginning cash position 149.79%84.36M190.94%160.63M145.88%192.99M10.73%52.46M149.79%84.36M-43.82%33.77M16.38%55.21M126.68%78.49M5.59%47.38M-43.82%33.77M
Current changes in cash 517.31%312.29M709.66%236.02M-39.00%-32.36M351.68%140.53M-334.50%-31.9M292.02%50.59M313.31%29.15M-281.66%-23.28M403.74%31.11M189.20%13.6M
End cash Position 370.18%396.65M370.18%396.65M190.94%160.63M145.88%192.99M10.73%52.46M149.79%84.36M149.79%84.36M16.38%55.21M126.68%78.49M5.59%47.38M
Free cash flow -43.81%-143.65M4.23%-23.12M-131.17%-53.91M-61.68%-35.34M-2.35%-31.3M1.45%-99.89M0.01%-24.14M17.78%-23.32M10.79%-21.86M-25.52%-30.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More